Dapagliflozin in Patients With Critical Illness

PHASE3CompletedINTERVENTIONAL
Enrollment

507

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 20, 2023

Study Completion Date

October 20, 2023

Conditions
Critical IllnessSepsis
Interventions
DRUG

Dapagliflozin 10mg Tab

Dapagliflozin 10 mg once per day for 14 days or until intensive care unit discharge or death

OTHER

Standard of Care

Current standard of care for management of critically ill patients

Trial Locations (23)

Unknown

Hospital de Emergência Dr. Daniel Houly, Arapiraca

Hospital e Maternidade São José, Colatina

Instituto de Ensino e Pesquisa do Hospital da Bahia, Salvador

Hospital Brasilia, Brasília

Hospital Municipal de Aparecida de Goiânia, Aparecida de Goiânia

Hospital Santa Lucia, Poços de Caldas

Hospital das Nações, Curitiba

Hospital Ecoville - Instituto de Neurologia de Curitiba, Curitiba

Hospital São Vicente de Paulo, Passo Fundo

Hospital Nossa Senhora da Oliveira, Vacaria

Hospital Baia Sul, Florianópolis

Hospital de Amor de Barretos, Barretos

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto

Hospital Nove de Julho, São Paulo

Santa Casa de Barretos, Barretos

Santa Casa de Curitiba, Curitiba

Hospital de Amor de Jales, Jales

Unimed Joinville, Joinville

Hospital São Lucas de Copacabana, Rio de Janeiro

Hospital Municipal Vila Santa Catarina, São Paulo

Hospital M´Boi Mirim, São Paulo

Hospital Santa Paula, São Paulo

49055-530

Centro de Pesquisa Clínica do Coração, Aracaju

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER